JNJ

Johnson & Johnson
D

JNJ

Arincen70/100B
285.92
USD
2.31
(0.81%)
Market Open
Last updated: · Delayed 15 min
Fair valueNot reliable
Q4 FY2026 · Earnings report
EPS estimate 2.91Revenue estimate 26.42B
OverviewFinancialsSignalsForecastEarningsDividendsCompany

Johnson & Johnson net income 1985–2026

Johnson & Johnson earned 210.00M USD in Q3 FY2026, the three months to 27 September 2026, down 95.9% on the same quarter a year before. Johnson & Johnson's net income over the last twelve months was 16.10B USD, down 35.9% on the twelve months before. In fiscal year 2025 it earned 26.80B USD, up 90.6% on the year before.

Last updated 7 Nov 2026 · Next report 26 Jan 2027

Net income

Net income · +5.7% a year over 10 yearsNet margin

Growth

Fiscal yearPeriod endingNet incomeGrowthNet marginRevenue
TTM27 Sept 202616.10B-35.92%16.20%99.34B
FY202528 Dec 202526.80B+90.56%28.46%94.19B
FY202429 Dec 202414.07B-59.99%15.84%88.82B
FY202331 Dec 202335.15B+95.94%41.28%85.16B
FY20221 Jan 202317.94B-14.07%22.43%79.99B
FY20212 Jan 202220.88B+41.89%26.52%78.74B
FY20203 Jan 202114.71B-2.68%17.82%82.58B
FY201931 Dec 201915.12B-1.16%18.42%82.06B
FY201831 Dec 201815.30B+1,076.69%18.75%81.58B
FY201731 Dec 20171.30B-92.14%1.70%76.45B
FY201631 Dec 201616.54B+7.34%23.01%71.89B
FY201531 Dec 201515.41B-5.60%21.99%70.07B
FY201431 Dec 201416.32B+18.02%21.96%74.33B
FY201331 Dec 201313.83B+27.44%19.40%71.31B
FY201231 Dec 201210.85B+12.21%16.14%67.22B
FY201131 Dec 20119.67B-27.46%14.87%65.03B
FY201031 Dec 201013.33B+8.71%21.65%61.59B
FY200931 Dec 200912.27B-5.27%19.82%61.90B
FY200831 Dec 200812.95B+22.44%20.31%63.75B
FY200731 Dec 200710.58B-4.32%17.31%61.10B
FY200631 Dec 200611.05B+9.87%20.73%53.32B
FY200531 Dec 200510.06B+22.98%19.92%50.51B
FY200431 Dec 20048.18B+13.66%17.28%47.35B
FY200331 Dec 20037.20B+9.10%17.19%41.86B
FY200231 Dec 20026.60B+16.39%18.17%36.30B
FY200131 Dec 20015.67B+14.44%17.54%32.32B
FY200031 Dec 20004.95B+15.91%16.98%29.17B
FY199931 Dec 19994.27B+42.29%15.26%28.01B
FY199831 Dec 19983.00B-9.08%12.52%24.00B
FY199731 Dec 19973.30B+14.41%14.60%22.63B
FY199631 Dec 19962.89B+20.14%13.35%21.62B
FY199531 Dec 19952.40B+19.79%12.75%18.84B
FY199431 Dec 19942.01B+12.26%12.75%15.73B
FY199331 Dec 19931.79B+73.50%12.64%14.14B
FY199231 Dec 19921.03B-29.50%7.49%13.75B
FY199131 Dec 19911.46B+27.82%11.74%12.45B
FY199031 Dec 19901.14B+5.64%10.18%11.23B
FY198931 Dec 19891.08B+11.09%11.09%9.76B
FY198831 Dec 1988974.00M+16.93%10.82%9.00B
FY198731 Dec 1987833.00M+152.81%10.40%8.01B
FY198631 Dec 1986329.50M-46.31%4.71%7.00B
FY198531 Dec 1985613.70M—9.56%6.42B

Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

See also:Revenue,EPS,Shares outstanding,Operating income,Cash on hand,Total debt,Free cash flow,Stock buybacks,Income statement

Common questions about Johnson & Johnson's profit

Source: Financial Modeling PrepVerified against SEC filings